AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore
University of California San Francisco at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
University of California San Francisco brings 6 presentations to AMP 2026 in Seattle. Its sessions cover solid tumor genomics, prenatal genetic testing, and laboratory and computing workflows. Presentations include methylation-based recurrence risk in low-grade uterine endometrioid adenocarcinoma, the diagnostic yield of prenatal genomic sequencing, and benchmarking GPU-accelerated variant calling against a standard pipeline.
| Organization | AMP 2026 Attendance |
|---|---|
University of California San Francisco San Francisco, CA | |
Public health sciences university in San Francisco with clinical laboratories and research in genomics and molecular diagnostics. | Talk Thu, Nov 12 11:15am–11:45am Novel Mutational Signatures in Cancer Two newly described mutational signatures, one tied to antiretroviral drugs and one to aristolochic acid. Workshop Thu, Nov 12 3:45pm–4:15pm Optimized Automated Extraction for FFPE Tissue Cores Automated simultaneous DNA and RNA extraction from FFPE cores and sections, validated for sequencing-grade yield. Talk Sat, Nov 14 10:45am–11:15am Diagnostic Yield of Prenatal Genomic Sequencing Diagnostic yield of exome and genome sequencing for fetal anomalies, including variants of uncertain significance. Poster Sat, Nov 14 1:45pm–2:00pm Poster Sat, Nov 14 7:15am–7:30am Talk Sat, Nov 14 7:30am–7:45am |
Find decision makers at University of California San Francisco
Tell us what you sell and we’ll find the people at University of California San Francisco most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction